Pharmacogenetics: Ethical issues and policy options

Abstract

: Pharmacogenetics offers the prospect of an era of safer and more effective drugs, as well as more individualized use of drug therapies. Before the benefits of pharmacogenetics can be realized, the ethical issues that arise in research and clinical application of pharmacogenetic technologies must be addressed. The ethical issues raised by pharmacogenetics can be addressed under six headings: regulatory oversight, confidentiality and privacy, informed consent, availability of drugs, access, and clinicians' changing responsibilities in the era of pharmacogenetic medicine. We analyze each of these categories of ethical issues and provide policy approaches for addressing them

Download options

PhilArchive



    Upload a copy of this work     Papers currently archived: 72,660

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2009-01-28

Downloads
54 (#213,869)

6 months
1 (#388,784)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Baruch Brody
PhD: Princeton University; Last affiliation: Rice University
Elizabeth McPherson
Bowling Green State University

References found in this work

No references found.

Add more references